UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000026688
Receipt No. R000030642
Official scientific title of the study Effect of dexmedetomidine in the prophylactic endoscopic injection sclerotherapy for esophageal varices: A study protocol for prospective interventional study
Date of disclosure of the study information 2017/03/25
Last modified on 2017/08/03 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effect of dexmedetomidine in the prophylactic endoscopic injection sclerotherapy for esophageal varices: A study protocol for prospective interventional study
Title of the study (Brief title) Effect of dexmedetomidine in the prophylactic endoscopic injection sclerotherapy for esophageal varices: A study protocol for prospective interventional study
Region
Japan

Condition
Condition Esophageal varices
Classification by specialty
Gastroenterology Hepato-biliary-pancreatic medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aims of the current study are to prospectively examine the safety and usefulness of DEX on sedation during prophylactic EIS for patients with EVs.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes (a)Decreasing rate in SpO2 during endoscopic procedures
(b)Increasing or decreasing rates in blood pressure during endoscopic procedures
(c)Pulse fluctuation during endoscopic procedures
(d)The rate of complications including disturbance or others
(e)Ramsey Sedation Scale values
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 The aims of the current study are to prospectively examine the safety and usefulness of DEX on sedation during prophylactic EIS for patients with EVs as compared with midazolam.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1.Patients with liver cirrhosis (LC) (diagnosed by liver histology or radiologic findings) who will require prophylactic EIS for EVs. Presence or absence of past history for endoscopic treatments for EVs is not required. Causes of LC are not also limited.
2. Child 5 or 6 or 7 points.
Key exclusion criteria Exclusion criteria
1.Poor liver function (Child-Pugh points of 8 or more)
2.Patients with severe comorbid diseases
3.Patients who were judged to be inappropriate for the study subjects
Target sample size 50

Research contact person
Name of lead principal investigator Shuhei Nishiguchi
Organization Hyogo college of medicine
Division name Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine
Address 1-1, Mukogawacho, Nishinomiyashi, Hyogo, 663-8501, Japan.
TEL 0798-45-6472
Email nishiguc@hyo-med.ac.jp

Public contact
Name of contact person Yoshinori Iwata
Organization Hyogo college of medicine
Division name Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine
Address 1-1, Mukogawacho, Nishinomiyashi, Hyogo, 663-8501, Japan.
TEL 0798-45-6472
Homepage URL
Email yo-iwata@hyo-med.ac.jp

Sponsor
Institute Hyogo college of medicine
Institute
Department

Funding Source
Organization Hyogo college of medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 03 Month 25 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2016 Year 09 Month 01 Day
Anticipated trial start date
2016 Year 09 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 03 Month 24 Day
Last modified on
2017 Year 08 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030642